Blood pressure targets achievement according to 2018 ESC/ESH guidelines in three european excellence centers for hypertension

Introduction The most recent European guidelines on hypertension rede ned o ce blood pressure (BP) treatment targets according to age strata and cardiovascular (CV) risk pro le. Aim To evaluate proportions of adult outpatients achieving o ce BP treatment targets recommended by current compared to previous hypertension guidelines. Methods We extracted data from medical databases of adult outpatients followed in three excellence centers in hyperten- sion (Rome, Italy; L’Aquila, Italy; Valencia, Spain). O ce BP treatment targets were de ned according to either 2013 ESH/ ESC guidelines (< 140/90 mmHg in non-diabetic individuals aged 18–80 years, < 150/90 mmHg in those aged ≥ 80 years, and < 140/85 mmHg in diabetic individuals), or 2018 ESC/ESH guidelines: (< 130/80 mmHg in individuals aged 18–65 years, < 140/80 mmHg in those aged 65–79 and ≥ 80 years). SCORE risk was assessed in all patients. Results From an overall sample of 14,229 adult subjects, 4049 (28.5%) resulted normotensive individuals, 3088 (21.7%) were untreated and 7092 (49.8%) treated hypertensive outpatients. Treated hypertensives showed signi cantly higher ESC score risk (8.3 ± 13.0% vs. 3.9 ± 8.4%; P < 0.001) and lower systolic/diastolic BP (140.6 ± 18.8/83.9 ± 11.5 vs. 148.3 ± 14.2/94.7 ± 10.1 mmHg; P < 0.001) than untreated hypertensives. Compared to previous guidelines, BP control signi cantly lowered in non-diabetic outpatients (n = 5847) of all age groups [18–65 years: (13.1% vs. 42.9%), 65–79 years (25.8% vs. 42.5%) and ≥ 80 years (29.1% vs. 66.0%); P < 0.001 for all comparisons]; similar reductions were observed in diabetic outpatients (n = 1245) [18–65 years (32.7% vs. 14.8%), 65–79 years (37.3% vs. 24.7%) and ≥ 80 years (47.1% vs. 27.9%); P < 0.001]. Conclusions According to the recommended new o ce BP treatment targets, the proportions of treated uncontrolled hyper- tensive patients substantially increased. These ndings should prompt a tighter application of therapeutic recommendations and, thus, highlight the need for improving hypertension management and control strategies.